Diabetes is accelerating at an alarming rate globally. Today, over 475 million people across all age groups and social classes, live with the chronic condition. What is even more worrying is the fact that this mostly goes undetected until it reaches life-threatening proportions.
The constant monitoring, apart from the actual treatment, makes diabetes management an expensive process. As a credible, global player in the area of diabetes, Biocon is committed to making therapies for diabetes management increasingly affordable and accessible across the globe.
